Tonghuashun (300033) Financial Research Center, May 14realbingoonline, some investors asked Derui Medical (300396)(300396)realbingoonline, the company's previous products covered seven series of urine analysis, biochemical analysis, blood cell analysis, chemiluminescent immunoassay, gynecological secretion analysis, coagulation analysis, and standardized laboratory. Are there any new breakthroughs or focuses in the current product series?
The company replied that after more than 30 years of independent research and development and innovation, the company's product series can meet more than 80% of the inspection project needs of the laboratory. The product system is gradually transforming towards intelligence and intensification. Urine analysis lines, biochemical immunity lines, integrated laboratories, etc. have been put on the market. After China Resources entered the company, it has provided support to Derui Medical in business expansion, brand building, and extended development. The company will also further improve operating efficiency and promote the company's high-quality development through China Resources 'rich experience in mergers and acquisitions and operation management.